Google Groups no longer supports new Usenet posts or subscriptions. Historical content remains viewable.
Dismiss
Repugs protect profits
4 views
Skip to first unread message
Baxter
Mar 19, 2020, 11:42:21 AM3/19/20
to
Big Pharma Prepares to Profit From the Coronavirus
Initially, some lawmakers had tried to ensure that the federal government
would limit how much pharmaceutical companies could reap from vaccines
and treatments for the new coronavirus that they developed with the use
of public funding. In February, Rep. Jan Schakowsky, D-Ill., and other
House members wrote to Trump pleading that he “ensure that any vaccine or
treatment developed with U.S. taxpayer dollars be accessible, available
and affordable,” a goal they said couldn’t be met “if pharmaceutical
corporations are given authority to set prices and determine
distribution, putting profit-making interests ahead of health
priorities.”
When the coronavirus funding was being negotiated, Schakowsky tried
again, writing to Health and Human Services Secretary Alex Azar on March
2 that it would be “unacceptable if the rights to produce and market that
vaccine were subsequently handed over to a pharmaceutical manufacturer
through an exclusive license with no conditions on pricing or access,
allowing the company to charge whatever it would like and essentially
selling the vaccine back to the public who paid for its development.”
But many Republicans opposed adding language to the bill that would
restrict the industry’s ability to profit, arguing that it would stifle
research and innovation. And although Azar, who served as the top
lobbyist and head of U.S. operations for the pharmaceutical giant Eli
Lilly before joining the Trump administration, assured Schakowsky that he
shared her concerns, the bill went on to enshrine drug companies’ ability
to set potentially exorbitant prices for vaccines and drugs they develop
with taxpayer dollars.
The final aid package not only omitted language that would have limited
drug makers’ intellectual property rights, it also left out language that
had been in an earlier draft that would have allowed the federal
government to take any action if it has concerns that the treatments or
vaccines developed with public funds are priced too high.
https://is.gd/KCHkxZ
Initially, some lawmakers had tried to ensure that the federal government
would limit how much pharmaceutical companies could reap from vaccines
and treatments for the new coronavirus that they developed with the use
of public funding. In February, Rep. Jan Schakowsky, D-Ill., and other
House members wrote to Trump pleading that he “ensure that any vaccine or
treatment developed with U.S. taxpayer dollars be accessible, available
and affordable,” a goal they said couldn’t be met “if pharmaceutical
corporations are given authority to set prices and determine
distribution, putting profit-making interests ahead of health
priorities.”
When the coronavirus funding was being negotiated, Schakowsky tried
again, writing to Health and Human Services Secretary Alex Azar on March
2 that it would be “unacceptable if the rights to produce and market that
vaccine were subsequently handed over to a pharmaceutical manufacturer
through an exclusive license with no conditions on pricing or access,
allowing the company to charge whatever it would like and essentially
selling the vaccine back to the public who paid for its development.”
But many Republicans opposed adding language to the bill that would
restrict the industry’s ability to profit, arguing that it would stifle
research and innovation. And although Azar, who served as the top
lobbyist and head of U.S. operations for the pharmaceutical giant Eli
Lilly before joining the Trump administration, assured Schakowsky that he
shared her concerns, the bill went on to enshrine drug companies’ ability
to set potentially exorbitant prices for vaccines and drugs they develop
with taxpayer dollars.
The final aid package not only omitted language that would have limited
drug makers’ intellectual property rights, it also left out language that
had been in an earlier draft that would have allowed the federal
government to take any action if it has concerns that the treatments or
vaccines developed with public funds are priced too high.
https://is.gd/KCHkxZ
BT
Mar 19, 2020, 12:14:33 PM3/19/20
to
Bax-Tart pasted in this:
> Pharma Prepares to Profit From the Coronavirus
You should talk. Big Pharma wanted Obama-Care, the Dems all
voted for it, and the Repubs voted against what Big Pharma
wanted, and you and your friends never made a peep.
So shut up!
B. T.
> Pharma Prepares to Profit From the Coronavirus
voted for it, and the Repubs voted against what Big Pharma
wanted, and you and your friends never made a peep.
So shut up!
B. T.
Jilad
Mar 19, 2020, 1:29:17 PM3/19/20
to
Baxter wrote:
> Big Pharma Prepares to Profit From the Coronavirus
You prefer they go bankrupt like say...the airlines?
> Big Pharma Prepares to Profit From the Coronavirus
I want your ass DEAD!
Jilad
Mar 19, 2020, 1:33:58 PM3/19/20
to
What a scumbag he is.
BT
Mar 19, 2020, 3:22:27 PM3/19/20
to
Jilad said:
> Shoe on other foot...er...in MOUTH!
Rather Boot Up Ass.
> Shoe on other foot...er...in MOUTH!
Come over here, Bax-Tart.
B. T.
Jilad
Mar 19, 2020, 3:40:54 PM3/19/20
to
0 new messages